Review: Dipeptidyl peptidase-4 inhibitors do not increase overall adverse events in type 2 diabetes

被引：2
|
作者：
Chatterjee, Saurav [1 ,2 ]
Chatterjee, Sanjay [3 ]
机构：
[1] Brown Univ, Providence, RI 02912 USA
[2] Providence VAMC, Providence, RI USA
[3] Apollo Gleneagles Hosp, Kolkata, W Bengal, India
来源：
ANNALS OF INTERNAL MEDICINE | 2013年 / 158卷 / 08期
关键词：
METAANALYSIS;
D O I：
10.7326/0003-4819-158-8-201304160-02008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Mellitus: Cardiovascular Safety
    Green, Jennifer B.
    POSTGRADUATE MEDICINE, 2012, 124 (04) : 54 - 61
  • [2] Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes
    Richter, Bernd
    Bandeira-Echtler, Elizabeth
    Bergerhoff, Karla
    Lerch, Christian
    VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (04) : 753 - 768
  • [3] Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes: Meta-Analysis
    Park, Haesuk
    Park, Chanhyun
    Kim, Yoona
    Rascati, Karen L.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (11) : 1453 - 1469
  • [4] Once-weekly dipeptidyl peptidase-4 inhibitors for type 2 diabetes: a systematic review and meta-analysis
    Stoimenis, Dimitrios
    Karagiannis, Thomas
    Katsoula, Anastasia
    Athanasiadou, Eleni
    Kazakos, Kyriakos
    Bekiari, Eleni
    Matthews, David R.
    Tsapas, Apostolos
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (09) : 843 - 851
  • [5] Effects of Dipeptidyl Peptidase-4 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
    Bae, Jae Hyun
    Kim, Sunhee
    Park, Eun-Gee
    Kim, Sin Gon
    Hahn, Seokyung
    Kim, Nam Hoon
    ENDOCRINOLOGY AND METABOLISM, 2019, 34 (01) : 80 - 92
  • [6] Effects of dipeptidyl peptidase-4 inhibitors on blood pressure in patients with type 2 diabetes: A systematic review and meta-analysis
    Zhang, Xiaodan
    Zhao, Qingyu
    JOURNAL OF HYPERTENSION, 2016, 34 (02) : 167 - 175
  • [7] Cardiovascular effects of dipeptidyl peptidase-4 inhibitors
    Papagianni, M.
    Tziomalos, K.
    HIPPOKRATIA, 2015, 19 (03) : 195 - 199
  • [8] The Effect of Dipeptidyl Peptidase-4 Inhibitors on Macrovascular and Microvascular Complications of Diabetes Mellitus: A Systematic Review
    Taylor, Olesya M.
    Lam, Christine
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2020, 93
  • [9] Effects of dipeptidyl peptidase-4 inhibitors on cardiac and endothelial function in type 2 diabetes mellitus: A pilot study
    Leung, Melissa
    Leung, Dominic Y.
    Wong, Vincent W.
    DIABETES & VASCULAR DISEASE RESEARCH, 2016, 13 (03) : 236 - 243
  • [10] Longer term safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: systematic review and meta-analysis
    Goossen, K.
    Graeber, S.
    DIABETES OBESITY & METABOLISM, 2012, 14 (12) : 1061 - 1072
12345